Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy

Abstract Context Elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta) enhances aberrant cystic fibrosis transmembrane conductance regulator function and may improve the insulin secretory defects associated with a deterioration in clinical outcomes in pancreatic insufficient cystic fibrosis (PI-CF). Obje...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The journal of clinical endocrinology and metabolism 2023-12, Vol.109 (1), p.151-160
Hauptverfasser:	Flatt, Anneliese J, Sheikh, Saba, Peleckis, Amy J, Alvarado, Paola, Hadjiliadis, Denis, Stefanovski, Darko, Gallop, Robert J, Rubenstein, Ronald C, Kelly, Andrea, Rickels, Michael R
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!